Is your child currently experiencing moderately to severely active IBD flare-ups? Local Crohn’s disease clinical research study is testing a potential new medication to see if it may reduce bloody diarrhea, abdominal cramps, abdominal pain, malnutrition, and/or liver disease associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the Crohn’s disease clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.

We are looking for children 2 to 17 years old to join a CD medical research study to help us discover more about treating moderate to severe UC. If you are looking for a potential new treatment option for moderate to severe UC or Crohn’s disease (including associated symptoms such as abdominal cramping, fever, constant need to poop, chronic fatigue and/or eye pain), consider one of our CD and UC studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the CD and UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

Is your child currently experiencing Crohn’s disease flare-ups? Local clinical trial is testing a potential new medication to see if it may reduce cramps, persistent diarrhea, abdominal pain, malnutrition, and/or canker sores associated with Crohn’s disease.
If you’re concerned about how Crohn’s disease affects your child’s life, find out more about the clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

We are looking for children and teenagers 2–17 years of age to join a clinical research to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or moderate to severe UC (including associated symptoms such as cramping, fistula, diarrhea, weight loss and/or eye pain), consider one of our CD studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the CD studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

Is your child currently experiencing ulcerative colitis flare-ups? Local clinical research study is testing a potential new medication to see if it may reduce weight loss, persistent diarrhea, constant need to poop, weight loss, and/or canker sores associated with ulcerative colitis.
If you’re concerned about how ulcerative colitis affects your child’s life, find out more about the clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for 2–17 year olds to join a CD research to help us discover more about treating ulcerative colitis (UC). If you are looking for a potential new treatment option for ulcerative colitis (UC) or moderate to severe Crohn’s disease (including associated symptoms such as stomach pain, joint pain, abdominal pain, malnutrition and/or anemia), consider one of our Crohn’s disease studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

Is your child currently experiencing inflammatory bowel disease flare-ups? Local Crohn’s disease (CD) clinical research study is testing a potential new medication to see if it may reduce recurrent diarrhea, abdominal cramps, constant need to poop, chronic fatigue, and/or liver disease associated with inflammatory bowel disease.
If you’re concerned about how inflammatory bowel disease affects your child’s life, find out more about the Crohn’s disease (CD) clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

We are looking for young people 2 to 17 years old to join a research to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or Crohn’s and ulcerative colitis (including associated symptoms such as chronic diarrhea, persistent diarrhea, rectal pain, weight loss and/or joint pain), consider one of our Crohn’s disease (CD) clinical research. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Is your child eligible?

Is your child currently experiencing Crohn’s disease (CD) flare-ups? Local Crohn’s disease (CD) clinical research study is testing a potential new medication to see if it may reduce recurrent diarrhea, reduced appetite, bloody stool, chronic fatigue, and/or canker sores associated with Crohn’s disease (CD).
If you’re concerned about how Crohn’s disease (CD) affects your child’s life, find out more about the Crohn’s disease (CD) clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to take part.

We are looking for young people 2 to 17 years old to join a CD clinical research to help us discover more about treating Crohn’s disease. If you are looking for a potential new treatment option for Crohn’s disease or IBD (including associated symptoms such as fever, perianal fistula, rectal pain, chronic fatigue and/or canker sores), consider one of our UC studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to take part.